
Lornicare P 8mg/325mg Tablet
Marketer
AB Allcare Biotech
Salt Composition
Lornoxicam (8mg) + Paracetamol (325mg)
Overview Lornicare P 8mg/325mg Tablet
Loripac 8mg/325mg tablets provide pain relief and reduce inflammation. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, and also alleviates muscle aches, back pain, toothaches, and ear/throat discomfort. For optimal absorption, Loripac should be administered on an empty stomach. Dosage is determined by your physician based on your specific needs and response to treatment. Always adhere to your doctor's prescribed dosage and duration. Common side effects may include nausea, vomiting, dyspepsia, abdominal pain, and diarrhea. Report any persistent or worsening side effects to your doctor, who can advise on mitigation strategies. Prior to commencing treatment, inform your doctor of any history of gastric ulcers or bleeding, hypertension, or pre-existing cardiac, renal, or hepatic conditions. Complete disclosure of all other medications you are currently using is crucial, as interactions may occur. Pregnant or lactating individuals should seek medical advice before using this medication. Alcohol consumption should be avoided during treatment due to the risk of increased drowsiness.
Uses of Lornicare P 8mg/325mg Tablet
Analgesia
Major Benefits of Lornicare P 8mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lornicare P 8mg/325mg Tablets. Swallow each tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Lornicare P 8mg/325mg Tablet:
- Nausea
- Vomiting
- Indigestion
- Stomach pain
- Diarrhea
How to use Lornicare P 8mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lornicare P 8mg/325mg Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Lornicare P 8mg/325mg Tablet works:
Each Lornicare P 8mg/325mg tablet combines lornoxicam and paracetamol to alleviate pain. This analgesic effect arises from inhibiting the production of chemical mediators responsible for pain and inflammation, thus reducing swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Lornicare P 8mg/325mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Data on Lornicare P 8mg/325mg Tablet use in pregnancy is currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Lornicare P 8mg/325mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Lornicare P 8mg/325mg Tablet on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Lornicare P 8mg/325mg tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Lornicare P 8mg/325mg tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Lornicare P 8mg/325mg Tablet :
Should you forget a Lornicare P 8mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lornicare P 8mg/325mg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Pain relievers |
